Reaction
Facial Palsy reporting signals
As of the last recalculation, Facial Palsy appears in 2,162 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is ZIPRASIDONE MESYLATE (PRR 12.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ziprasidone Mesylate | 19 | 12.9 | 13.0 |
| Ziprasidone | 19 | 10.5 | 10.5 |
| Salmeterol Xinafoate | 9 | 10.1 | 10.1 |
| Valsartan And Hydrochlorothiazide | 13 | 9.3 | 9.3 |
| Gemfibrozil | 14 | 8.9 | 8.9 |
| Peginterferon Alfa-2A | 46 | 8.3 | 8.4 |
| Onabotulinumtoxina | 58 | 7.4 | 7.4 |
| Ribavirin | 48 | 7.3 | 7.3 |
| Efavirenz | 8 | 6.9 | 6.9 |
| Mercaptopurine | 12 | 6.7 | 6.7 |
| Raloxifene Hydrochloride | 10 | 6.6 | 6.6 |
| Temozolomide | 14 | 6.4 | 6.4 |
| Fondaparinux Sodium | 5 | 6.0 | 6.0 |
| Interferon Beta-1B | 11 | 5.5 | 5.6 |
| Metformin Hcl | 26 | 4.6 | 4.6 |
| Botulinum Toxin Type A | 5 | 3.9 | 3.9 |
| Irinotecan Hydrochloride | 5 | 3.7 | 3.8 |
| Varenicline Tartrate | 30 | 3.6 | 3.6 |
| Sevoflurane | 3 | 3.5 | 3.5 |
| Interferon Beta-1A | 67 | 3.4 | 3.4 |
| Isotretinoin | 16 | 3.1 | 3.1 |
| Agalsidase Beta | 3 | 3.1 | 3.1 |
| Ranibizumab | 7 | 2.5 | 2.5 |
| Glycerin, Lidocaine | 3 | 2.1 | 2.1 |
| Vigabatrin | 3 | 2.0 | 2.0 |
| Docosanol | 3 | 2.0 | 2.0 |